Matt Browne

    • Shoreline Biosciences Closes $140 Million Funding 

    • Sixth Street Invests in Blueprint Medicines 

    • Billtrust to Combine With South Mountain, a Special Purpose Acquisition Company, at $1.3 Billion Value 

    • Oberland Capital in financing of Agenus 

    • AcelRx sale of Zalviso® royalties to PDL BioPharma  

    • Renovate America Series F financing  

    • TPG Special Situations Partners purchase of Kadcyla® royalties from ImmunoGen  

    • Volcano Corp. Acquired by Royal Philips NV for $1.2 Billion 

    • Volcano Acquired by Philips for $1.2 Billion 

    • Insys Therapeutics IPO